BioNeutra Global Corp. engages in the in the business of research and development, production, and commercialization of ingredients for nutraceutical, functional, and mainstream foods and beverages. The company is headquartered in Edmonton, Alberta. The company went IPO on 2014-11-05. The Company’s lead product, VitaFiber IMO, is an advanced functional and health food ingredient naturally derived from agricultural products. VitaFiber IMO is naturally sweet and lower in calories than sugar and is a natural source of dietary fiber as it provides low calorie soluble prebiotic fiber for human digestive health. The company produces VitaFiber IMO using its patented production processes that naturally transform starch molecules from agriculture cereal crops, including tapioca, field pea or corn, into the functional health molecules of isomalto-oligosaccharide. VitaFiber IMO is also available for retail purchase across the globe through Amazon.com and Shopify.com. The Company’s customers include a mix of small and medium enterprises.
최신 재무제표(Form-10K)에 따르면, BioNeutra Global Corporation의 총 자산은 $15이며, 순손실입니다.
BGACF의 주요 재무 비율은 무엇인가요?
BioNeutra Global Corporation의 유동비율은 0.71이고, 순이익률은 -18.18, 주당 매출은 $0.23입니다.
BioNeutra Global Corporation의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
BioNeutra Global Corporation 주요 수익원은 Syrup이며, 최신 수익 발표에서 수익은 8,601,929입니다. 지역별로는 United States이 BioNeutra Global Corporation의 주요 시장이며, 수익은 8,485,700입니다.
BioNeutra Global Corporation은 수익성이 있나요?
no, 최신 재무제표에 따르면 BioNeutra Global Corporation의 순손실은 $-2입니다.